Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5527)
Apellis Pharmaceuticals, Inc. (APLS)
Francois Cedric — Director
Shares
27,192
Price
$21.77
Total Value
$591.84K
Shares Held After
286,045
% of Holdings
8.7%
Apellis Pharmaceuticals, Inc. (APLS)
Nicholson Nur — Chief Technical Officer
Shares
7,725
Price
$21.77
Total Value
$168.14K
Shares Held After
71,118
% of Holdings
9.8%
Apellis Pharmaceuticals, Inc. (APLS)
Sullivan Timothy Eugene — Chief Financial Officer
Shares
10,287
Price
$21.77
Total Value
$223.90K
Shares Held After
93,901
% of Holdings
9.9%
Apellis Pharmaceuticals, Inc. (APLS)
Watson David O. — General Counsel
Shares
7,832
Price
$21.77
Total Value
$170.47K
Shares Held After
88,531
% of Holdings
8.1%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
14,300
Price
$110.16
Total Value
$1.58M
Shares Held After
59,634
% of Holdings
19.3%
Scholar Rock Holding Corp (SRRK)
Qatanani Mo — CHIEF SCIENTIFIC OFFICER
Shares
12,779
Price
$46.85
Total Value
$598.75K
Shares Held After
85,660
% of Holdings
13.0%
Scholar Rock Holding Corp (SRRK)
Qatanani Mo — CHIEF SCIENTIFIC OFFICER
Shares
2,119
Price
$45.87
Total Value
$97.19K
Shares Held After
98,439
% of Holdings
2.1%
Cullinan Therapeutics, Inc. (CGEM)
Michaelson Jennifer — Chief Scientific Officer
Shares
4,000
Price
$12.30
Total Value
$49.20K
Shares Held After
128,635
% of Holdings
3.0%
IONIS PHARMACEUTICALS INC (IONS)
Devers Shannon L. — EVP, Chief Human Resources Ofc
Shares
3,977
Price
$81.34
Total Value
$323.49K
Shares Held After
22,541
% of Holdings
15.0%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
2,173
Price
$56.57
Total Value
$122.92K
Shares Held After
448,693
% of Holdings
0.5%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
12,665
Price
$5.32
Total Value
$67.38K
Shares Held After
605,159
% of Holdings
2.0%
Mirum Pharmaceuticals, Inc. (MIRM)
Howe Jolanda — SVP, GLOBAL CONTROLLER
Shares
926
Price
$93.33
Total Value
$86.42K
Shares Held After
3,042
% of Holdings
23.3%
Mirum Pharmaceuticals, Inc. (MIRM)
Quan Joanne — CHIEF MEDICAL OFFICER
Shares
1,822
Price
$93.33
Total Value
$170.04K
Shares Held After
12,817
% of Holdings
12.4%
Mirum Pharmaceuticals, Inc. (MIRM)
BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Shares
1,421
Price
$93.33
Total Value
$132.62K
Shares Held After
42,127
% of Holdings
3.3%
Mirum Pharmaceuticals, Inc. (MIRM)
Radovich Peter — PRESIDENT AND COO
Shares
2,382
Price
$93.33
Total Value
$222.30K
Shares Held After
20,679
% of Holdings
10.3%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
7,098
Price
$93.33
Total Value
$662.42K
Shares Held After
163,733
% of Holdings
4.2%
Acumen Pharmaceuticals, Inc. (ABOS)
Meisner Derek M — Chief Legal Officer & Corp Sec
Shares
1,054
Price
$1.84
Total Value
$1.94K
Shares Held After
179,632
% of Holdings
0.6%
Acumen Pharmaceuticals, Inc. (ABOS)
Siemers Eric — Chief Medical Officer
Shares
895
Price
$1.82
Total Value
$1.63K
Shares Held After
255,371
% of Holdings
0.3%
Acumen Pharmaceuticals, Inc. (ABOS)
Zuga Matt — CFO & Chief Business Officer
Shares
1,687
Price
$1.86
Total Value
$3.14K
Shares Held After
304,924
% of Holdings
0.6%
Acumen Pharmaceuticals, Inc. (ABOS)
OConnell Daniel Joseph — Director
Shares
2,689
Price
$1.88
Total Value
$5.07K
Shares Held After
881,275
% of Holdings
0.3%
Acumen Pharmaceuticals, Inc. (ABOS)
Barton Russell — Chief Operating Officer
Shares
462
Price
$1.84
Total Value
$850.08
Shares Held After
205,092
% of Holdings
0.2%
Personalis, Inc. (PSNL)
Tachibana Aaron — CFO AND COO
Shares
1,201
Price
$11.50
Total Value
$13.81K
Shares Held After
164,458
% of Holdings
0.7%
CareDx, Inc. (CDNA)
Hanna John Walter JR — Director
Shares
19,280
Price
$21.16
Total Value
$408.02K
Shares Held After
597,405
% of Holdings
3.1%
Axsome Therapeutics, Inc. (AXSM)
Pizzie Nick — Chief Financial Officer
Shares
12,000
Price
$187.92
Total Value
$2.26M
Shares Held After
42,588
% of Holdings
22.0%
ABEONA THERAPEUTICS INC. (ABEO)
Vazzano Joseph Walter — Chief Financial Officer
Shares
18,666
Price
$5.33
Total Value
$99.51K
Shares Held After
568,560
% of Holdings
3.2%
ABEONA THERAPEUTICS INC. (ABEO)
Seshadri Vishwas — Director
Shares
69,832
Price
$5.33
Total Value
$372.27K
Shares Held After
1,460,408
% of Holdings
4.6%
ABEONA THERAPEUTICS INC. (ABEO)
O'Malley Brendan M. — SVP, Chief Legal Officer
Shares
13,578
Price
$5.33
Total Value
$72.38K
Shares Held After
451,134
% of Holdings
2.9%
Cogent Biosciences, Inc. (COGT)
Fairmount Funds Management LLC — Director
Shares
3,500,000
Price
$36.40
Total Value
$127.40M
Shares Held After
5,503,418
% of Holdings
38.9%
Apogee Therapeutics, Inc. (APGE)
Fairmount Funds Management LLC — Director
Shares
1,750,000
Price
$76.30
Total Value
$133.53M
Shares Held After
298,647
% of Holdings
85.4%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
1,283
Price
$42.68
Total Value
$54.76K
Shares Held After
16,680
% of Holdings
7.1%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
11,875
Price
$41.91
Total Value
$497.66K
Shares Held After
18
% of Holdings
99.8%
Precision BioSciences, Inc. (DTIL)
Amoroso Michael — Director
Shares
34,799
Price
$4.17
Total Value
$145.11K
Shares Held After
196,154
% of Holdings
15.1%
CRISPR Therapeutics AG (CRSP)
Kulkarni Samarth — Director
Shares
60,000
Price
$60.23
Total Value
$3.61M
Shares Held After
134,201
% of Holdings
30.9%
InspireMD, Inc. (NSPR)
Gleason Shane Thomas — Chief Commercial Officer
Shares
17,593
Price
$1.62
Total Value
$28.55K
Shares Held After
1,174,664
% of Holdings
1.5%
Edgewise Therapeutics, Inc. (EWTX)
Edris Badreddin — Director
Shares
66,477
Price
$29.44
Total Value
$1.96M
Shares Held After
19,820
% of Holdings
77.0%
Edgewise Therapeutics, Inc. (EWTX)
Edris Badreddin — Director
Shares
10,463
Price
$29.44
Total Value
$308.03K
Shares Held After
86,297
% of Holdings
10.8%
Edgewise Therapeutics, Inc. (EWTX)
Edris Badreddin — Director
Shares
7,605
Price
$29.44
Total Value
$223.89K
Shares Held After
96,760
% of Holdings
7.3%
Edgewise Therapeutics, Inc. (EWTX)
Edris Badreddin — Director
Shares
17,236
Price
$29.44
Total Value
$507.43K
Shares Held After
104,365
% of Holdings
14.2%
Edgewise Therapeutics, Inc. (EWTX)
Edris Badreddin — Director
Shares
13,690
Price
$29.44
Total Value
$403.03K
Shares Held After
121,601
% of Holdings
10.1%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
1,977
Price
$26.03
Total Value
$51.46K
Shares Held After
197,634
% of Holdings
1.0%
Allogene Therapeutics, Inc. (ALLO)
Roberts Zachary — EVP of R&D
Shares
26,269
Price
$1.56
Total Value
$40.98K
Shares Held After
616,866
% of Holdings
4.1%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
3,749
Price
$97.94
Total Value
$367.18K
Shares Held After
0
% of Holdings
100.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
553
Price
$95.49
Total Value
$52.81K
Shares Held After
3,749
% of Holdings
12.9%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
700
Price
$109.84
Total Value
$76.89K
Shares Held After
59,634
% of Holdings
1.2%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — General Counsel
Shares
908
Price
$115.60
Total Value
$104.96K
Shares Held After
46,976
% of Holdings
1.9%
Avidity Biosciences, Inc. (RNAM)
Hughes Steven George — Chief Medical Officer
Shares
2,878
Price
$72.45
Total Value
$208.51K
Shares Held After
31,599
% of Holdings
8.3%
Avidity Biosciences, Inc. (RNAM)
Hughes Steven George — Chief Medical Officer
Shares
2,017
Price
$72.45
Total Value
$146.13K
Shares Held After
34,477
% of Holdings
5.5%
Avidity Biosciences, Inc. (RNAM)
Boyce Sarah — Director
Shares
7,993
Price
$72.45
Total Value
$579.09K
Shares Held After
269,007
% of Holdings
2.9%
Avidity Biosciences, Inc. (RNAM)
Boyce Sarah — Director
Shares
6,394
Price
$72.45
Total Value
$463.25K
Shares Held After
277,000
% of Holdings
2.3%
Avidity Biosciences, Inc. (RNAM)
Flanagan W. Michael — Chief Scientific Officer
Shares
2,558
Price
$72.45
Total Value
$185.33K
Shares Held After
85,093
% of Holdings
2.9%
Showing 3651–3700 of 5527 transactions (page 74 of 111)